The Wnt/β-catenin signalling pathway in Haematological Neoplasms
Abstract Leukaemia and lymphoma are common malignancies. The Wnt pathway is a complex network of proteins regulating cell proliferation and differentiation, as well as cancer development, and is divided into the Wnt/β-catenin signalling pathway (the canonical Wnt signalling pathway) and the noncanon...
Main Authors: | Siwei Yu, Ruyue Han, Runliang Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40364-022-00418-9 |
Similar Items
-
Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review
by: Catriona Parker, et al.
Published: (2022-05-01) -
Advances in the application of Raman spectroscopy in haematological tumours
by: Haoyue Liang, et al.
Published: (2023-01-01) -
Sevoflurane inhibits cholangiocarcinoma via Wnt/β-catenin signaling pathway
by: Hui Cheng, et al.
Published: (2023-08-01) -
A systematic review and meta-analysis of haematological malignancies in residents living near petrochemical facilities
by: Calvin Jephcote, et al.
Published: (2020-05-01) -
Concurrent epigenetic silencing of wnt/β-catenin pathway inhibitor genes in B cell chronic lymphocytic leukaemia
by: Moskalev Evgeny A, et al.
Published: (2012-06-01)